Es gab 50 kürzliche Insider-Transaktionen für Karuna Therapeutics, Inc. (KRTX), darunter 16 Käufe und 32 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $16.89M und die gesamten Insider-Verkäufe auf $49.48M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Jonas Jeffrey M, Coughlin Christopher J, Paul Steven M. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — KRTX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-03-18 |
Jonas Jeffrey M |
Director |
Aktienrückgabe |
1,904 |
$237.70 |
$452.58K |
- |
| 2024-03-18 |
Coughlin Christopher J |
Director |
Aktienrückgabe |
1,904 |
$237.70 |
$452.58K |
- |
| 2024-03-18 |
Paul Steven M |
Director |
Aktienrückgabe |
135,992 |
$99.72 |
$13.56M |
- |
| 2024-03-18 |
Healy James |
Director |
Aktienrückgabe |
1,904 |
$237.70 |
$452.58K |
- |
| 2024-03-18 |
Meury William |
President and CEO |
Aktienrückgabe |
63,065 |
$193.19 |
$12.18M |
- |
| 2024-03-18 |
Olson Laurie J |
Director |
Aktienrückgabe |
1,904 |
$237.70 |
$452.58K |
- |
| 2024-03-18 |
Pande Atul |
Director |
Aktienrückgabe |
1,904 |
$237.70 |
$452.58K |
- |
| 2024-03-18 |
Brannan Stephen K. |
Chief Medical Officer |
Aktienrückgabe |
17,350 |
$187.26 |
$3.25M |
- |
| 2024-03-18 |
Miller Andrew Craig |
President of R&d |
Aktienrückgabe |
9,412 |
$330.00 |
$3.11M |
- |
| 2024-03-18 |
Wheadon David E. |
Director |
Aktienrückgabe |
1,904 |
$237.70 |
$452.58K |
- |
| 2024-03-18 |
Kane William P Jr |
Chief Commercial Officer |
Aktienrückgabe |
29,937 |
$192.15 |
$5.75M |
- |
| 2024-03-18 |
Torres Denice |
Director |
Aktienrückgabe |
1,904 |
$237.70 |
$452.58K |
- |
| 2024-03-18 |
Brown Jason Parker |
Chief Financial Officer |
Aktienrückgabe |
7,696 |
$169.09 |
$1.3M |
- |
| 2024-03-08 |
Brannan Stephen K. |
Chief Medical Officer |
Optionsausübung (Verkauf) |
2,500 |
$5.45 |
$13.63K |
4,677 |
| 2024-03-04 |
Paul Steven M |
Director |
Schenkung (gegeben) |
30,304 |
- |
- |
2,364 |
| 2024-03-01 |
Paul Steven M |
Director |
Schenkung (gegeben) |
30,304 |
- |
- |
10,000 |
| 2024-02-29 |
Paul Steven M |
Director |
Sonstige (Kauf) |
47,378 |
$315.18 |
$14.93M |
70,608 |
| 2024-02-23 |
Paul Steven M |
Director |
Optionsausübung |
27,510 |
$7.27 |
$200K |
38,106 |
| 2024-02-13 |
Meury William |
President and CEO |
RSU-Zuteilung |
38,688 |
- |
- |
38,688 |
| 2024-02-13 |
Brannan Stephen K. |
Chief Medical Officer |
RSU-Zuteilung |
10,306 |
- |
- |
10,306 |
| 2024-02-13 |
Miller Andrew Craig |
President of R&d |
RSU-Zuteilung |
15,855 |
- |
- |
15,855 |
| 2024-02-13 |
Kane William P Jr |
Chief Commercial Officer |
RSU-Zuteilung |
10,306 |
- |
- |
10,306 |
| 2024-02-13 |
Brown Jason Parker |
Chief Financial Officer |
RSU-Zuteilung |
10,306 |
- |
- |
10,306 |
| 2024-02-09 |
Paul Steven M |
Director |
RSU-Steuereinbehalt |
804 |
$317.14 |
$254.98K |
10,596 |
| 2024-02-09 |
Brannan Stephen K. |
Chief Medical Officer |
RSU-Steuereinbehalt |
1,046 |
$317.14 |
$331.73K |
40,104 |
| 2024-02-09 |
Miller Andrew Craig |
President of R&d |
RSU-Steuereinbehalt |
1,011 |
$317.14 |
$320.63K |
23,389 |
| 2024-02-08 |
Brannan Stephen K. |
Chief Medical Officer |
Optionsausübung (Verkauf) |
2,500 |
$5.45 |
$13.63K |
7,177 |
| 2024-01-08 |
Brannan Stephen K. |
Chief Medical Officer |
Optionsausübung (Verkauf) |
2,500 |
$5.45 |
$13.63K |
9,677 |
| 2023-12-28 |
Meury William |
President and CEO |
RSU-Steuereinbehalt |
8,694 |
$316.30 |
$2.75M |
29,379 |
| 2023-12-28 |
Kane William P Jr |
Chief Commercial Officer |
RSU-Steuereinbehalt |
3,828 |
$316.30 |
$1.21M |
13,828 |
| 2023-12-08 |
Brannan Stephen K. |
Chief Medical Officer |
Optionsausübung (Verkauf) |
2,500 |
$5.45 |
$13.63K |
12,177 |
| 2023-11-08 |
Brannan Stephen K. |
Chief Medical Officer |
Optionsausübung (Verkauf) |
2,500 |
$5.45 |
$13.63K |
14,677 |
| 2023-10-09 |
Brannan Stephen K. |
Chief Medical Officer |
Optionsausübung (Verkauf) |
2,500 |
$5.45 |
$13.63K |
17,177 |
| 2023-09-29 |
Brown Jason Parker |
Chief Financial Officer |
Veräußerung |
7,100 |
$191.79 |
$1.36M |
- |
| 2023-09-29 |
Brown Jason Parker |
Chief Financial Officer |
RSU-Zuteilung |
7,696 |
$169.09 |
$1.3M |
7,696 |
| 2023-09-08 |
Brannan Stephen K. |
Chief Medical Officer |
Optionsausübung (Verkauf) |
2,500 |
$5.45 |
$13.63K |
19,677 |
| 2023-09-01 |
Jonas Jeffrey M |
Director |
Informierter Verkauf |
399 |
$188.98 |
$75.4K |
990 |
| 2023-08-22 |
Ignelzi Troy A. |
Chief Financial Officer |
Informierter Verkauf |
60 |
$176.60 |
$10.6K |
30,487 |
| 2023-08-08 |
Brannan Stephen K. |
Chief Medical Officer |
Optionsausübung (Verkauf) |
2,500 |
$5.45 |
$13.63K |
22,177 |
| 2023-08-01 |
Jonas Jeffrey M |
Director |
Informierter Verkauf |
600 |
$198.41 |
$119.05K |
990 |
| 2023-07-03 |
Jonas Jeffrey M |
Director |
Informierter Verkauf |
2,409 |
$217.82 |
$524.73K |
990 |
| 2023-07-03 |
Olson Laurie J |
Director |
Informierter Verkauf |
400 |
$216.03 |
$86.41K |
990 |
| 2023-06-20 |
Jonas Jeffrey M |
Director |
RSU-Zuteilung |
990 |
- |
- |
990 |
| 2023-06-20 |
Coughlin Christopher J |
Director |
RSU-Zuteilung |
990 |
- |
- |
990 |
| 2023-06-20 |
Healy James |
Director |
RSU-Zuteilung |
1,904 |
$237.70 |
$452.58K |
1,904 |
| 2023-06-20 |
Olson Laurie J |
Director |
RSU-Zuteilung |
990 |
- |
- |
990 |
| 2023-06-20 |
Pande Atul |
Director |
RSU-Zuteilung |
990 |
- |
- |
990 |
| 2023-06-20 |
Wheadon David E. |
Director |
RSU-Zuteilung |
990 |
- |
- |
990 |
| 2023-06-20 |
Torres Denice |
Director |
RSU-Zuteilung |
990 |
- |
- |
990 |
| 2023-06-14 |
Healy James |
Director |
Sonstige (Kauf) |
8,025 |
- |
- |
8,025 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
